Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Shinichiro Machida"'
Autor:
Makoto Onizuka, Tadashi Imanishi, Kaito Harada, Yasuyuki Aoyama, Jun Amaki, Masako Toyosaki, Shinichiro Machida, Eri Kikkawa, Sanetoshi Yamada, Kazuhiko Nakabayashi, Kenichiro Hata, Ken Higashimoto, Hidenobu Soejima, Kiyoshi Ando
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-6 (2023)
Abstract Cord blood stem cell transplantation is an important alternative for patients needing hematopoietic stem cell transplantation. However, it is unclear how cord blood cells, which are 0 years old, age in the recipient’s body after allogeneic
Externí odkaz:
https://doaj.org/article/314c33dbb52f48e191278cd7a0bc3331
Autor:
Hidetsugu Kawai, Hiromichi Matsushita, Ken Ohmachi, Minoru Kojima, Shinichiro Machida, Yoshiaki Ogawa, Hiroshi Kawada, Naoya Nakamura, Kiyoshi Ando
Publikováno v:
Leukemia Research Reports, Vol 5, Iss C, Pp 3-6 (2016)
Hepatosplenic T-cell lymphoma (HSTCL), a rare type of γδ T-cell lymphoma, is characterized by hepatosplenomegaly and cytopenias. It is associated with immunodeficiency and its age of onset is reportedly between the 20s and 30s. We herein report 4 J
Externí odkaz:
https://doaj.org/article/efede19e8a3848818bebe9cbfb4cca75
Autor:
Kaito Harada, Noriko Doki, Jun Aoki, Jinichi Mori, Shinichiro Machida, Masayoshi Masuko, Naoyuki Uchida, Yuho Najima, Takahiro Fukuda, Heiwa Kanamori, Hiroyasu Ogawa, Shuichi Ota, Kazuei Ogawa, Satoshi Takahashi, Masanobu Kasai, Akio Maeda, Koji Nagafuji, Toshiro Kawakita, Tatsuo Ichinohe, Yoshiko Atsuta
Publikováno v:
Haematologica, Vol 103, Iss 2 (2018)
Externí odkaz:
https://doaj.org/article/bfe2911fceab4be7be1f539fad63c9ca
Autor:
Minoru Kojima, Daisuke Ogiya, Akifumi Ichiki, Ryujiro Hara, Jun Amaki, Hidetsugu Kawai, Hiroki Numata, Ai Sato, Mitsuki Miyamoto, Rikio Suzuki, Shinichiro Machida, Hiromichi Matsushita, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando
Publikováno v:
Leukemia Research Reports, Vol 5, Iss C, Pp 11-13 (2016)
A 40-year-old male developed refractory acute promyelocytic leukemia (APL) after various treatments including all-trans retinoic acid, tamibarotene, arsenic trioxide (As2O3), conventional chemotherapy, and autologous peripheral blood stem cell transp
Externí odkaz:
https://doaj.org/article/173e03a47bf64722a7829c5b291bf530
Autor:
Daisuke Ogiya, Norie Murayama, Yusuke Kamiya, Rie Saito, Sawako Shiraiwa, Rikio Suzuki, Shinichiro Machida, Kei Tazume, Kiyoshi Ando, Hiroshi Yamazaki
Publikováno v:
Annals of Hematology. 101:2013-2019
Lenalidomide is a synthetic analog of thalidomide formed by the removal of one keto group (plus the addition of an amino group); it has anti-tumor activities beneficial for the treatment of hematologic malignancies. However, lenalidomide distribution
Autor:
Miyako Takahashi, Katsuhiro Shono, Takahiko Sato, Shin ichiro Fujiwara, Akio Kohno, Takuhiro Yamaguchi, Yukari Umemoto, Masatsugu Tanaka, Saiko Kurosawa, Ayako Mori, Tadakazu Kondo, Seiko Kato, Tomoko Matsuura, Satoshi Yoshioka, Takehiko Mori, Yuta Katayama, Shinichiro Machida, Ishikazu Mizuno, Hideki Goto, Takahiro Fukuda
Publikováno v:
Journal of Cancer Survivorship. 16:1004-1015
To characterize the issues regarding work and employment specific to allogeneic hematopoietic cell transplantation (allo-HCT) survivors, we conducted a nationwide cross-sectional questionnaire survey. We targeted allo-HCT survivors employed at diagno
Autor:
Sawako Shiraiwa, Kaito Harada, Makoto Onizuka, Shohei Kawakami, Ryujiro Hara, Yasuyuki Aoyama, Jun Amaki, Daisuke Ogiya, Rikio Suzuki, Masako Toyosaki, Shinichiro Machida, Ken Omachi, Hiroshi Kawada, Yoshiaki Ogawa, Kiyoshi Ando
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 28(9)
Influenza virus infection (IVI) is frequent in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients, and reports from several countries indicate high morbidity and mortality from progression to lower respiratory tract disease (LR
Autor:
Tatsuo Ichinohe, Shingo Yano, Takahiro Fukuda, Shinichiro Machida, Makoto Onizuka, Kazuteru Ohashi, Koji Iwato, Yoshiko Atsuta, Tetsuya Eto, Kazuhiro Ikegame, Jun Aoki, Takaaki Konuma, Naoyuki Uchida, Masatsugu Tanaka, Jinichi Mori, Yukiyasu Ozawa, Kaito Harada
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:1730-1743
Although the prognosis of acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) is worse than that of AML not otherwise specified (AML-NOS), transplantation outcomes and prognosticators of AML-MRC patients undergoing allogeneic stem ce
Autor:
Masao Ogata, Atae Utsunomiya, Koji Kato, Kaoru Uchimaru, Ilseung Choi, Rika Sakai, Shinichiro Machida, Yoshitaka Inoue, Yasushi Sawayama, Takahiro Fukuda, Junya Makiyama, Tsutomu Takahashi, Ayumu Ito, Takashi Tanaka, Yoshihiro Inamoto, Shigeo Fuji, Nobuaki Nakano, Souichi Shiratori, Toshiro Kawakita, Tomohiko Kamimura, Koji Nagafuji, Ken Takase, Hirohisa Nakamae
Publikováno v:
Blood advances. 5(20)
Aggressive adult T-cell leukemia/lymphoma (ATL) is a hematological malignancy that is difficult to treat with chemotherapy alone, and allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapy. We conducted a multicent
Autor:
Akifumi Ichiki, Daisuke Furuya, Daisuke Ogiya, Shohei Kawakami, Sawako Shiraiwa-Hara, Rikio Suzuki, Shinichiro Machida, Makoto Onizuka, Hiromichi Matsushita, Yoshiaki Ogawa, Naoya Nakamura, Hiroshi Kawada, Yasuyuki Aoyama, Ryujiro Hara, Hidetsugu Kawai, Kiyoshi Ando, Yukari Shirasugi
Publikováno v:
Journal of Clinical and Experimental Hematopathology : JCEH
Composite lymphoma (CL) is defined as the occurrence of two distinct types of lymphoma within the same patient. Most cases of CL involve Hodgkin and non-Hodgkin lymphomas or two distinct types of B-cell lymphomas; true CL is a composite B-cell and T-